Nov 7, 2022, 17:02 by Bob Davis

In response to significant member interest, ASAM developed a report detailing the availability of buprenorphine at pharmacies. The report is divided into two versions: a shorter, topline brief and a longer form report with information about methodology, statistical analysis, and data visualization charts.

Nov 2, 2022, 13:47 by Molly McGrath

On November 1st, the California Society of Addiction Medicine (CSAM) sent written comments to the California Department of Insurance in response to their prenotice public discussion for the implementation of SB 855.

Nov 2, 2022, 08:00 by Bob Davis

Nov 1, 2022, 11:00 by Bob Davis

Oct 27, 2022, 09:21 by Bob Davis

On October 25th, the Arkansas Society of Addiction Medicine (ARSAM) sent a letter to the Arkansas Medicaid Drug Review Committee (DRC) urging for the committee to remove utilization management restrictions on long-acting injectable medications.

Oct 25, 2022, 15:01 by Bob Davis

Oct 20, 2022, 08:53 by Bob Davis

On October 14th, ASAM held its second annual virtual State Advocacy Summit for state chapter members. This three-hour, members-only event was divided into five main sessions and included ASAM members from 33 states, who represent 32 of ASAM’s state chapters.

Oct 18, 2022, 14:57 by Bob Davis

Oct 17, 2022, 08:36 by Bob Davis

Specialists share inspiring stories urging the medical community to treat addiction and save lives

Oct 13, 2022, 08:57 by Bob Davis

ASAM has released two new public policy statements with recommendations for improving addiction care in the United States. The first, “Optimizing Telehealth Access to Addiction Care,” focuses on the role of telehealth in treating addiction. The second, “Substance Use and Substance Use Disorder Among Pregnant and Postpartum People,” includes policy recommendations for improving health outcomes for pregnant and postpartum people who use substances or have substance use disorder (SUD).

Oct 11, 2022, 02:00 by Bob Davis

Oct 4, 2022, 02:00 by Bob Davis

Oct 3, 2022, 09:32 by Bob Davis

New Edition of “The ASAM Criteria” to be published by Hazelden Publishing. A book of standards at the center of America’s addiction treatment ecosystem will soon be updated and enhanced to facilitate better care for the millions of people diagnosed with substance use disorders each year.

Sep 29, 2022, 07:46 by Molly McGrath

Sep 28, 2022, 11:34 by Molly McGrath

On September 28th, ASAM wrote to the Chair Richard Neal and Ranking Member Kevin Brady of the U.S. House Ways and Means Committee.

Sep 27, 2022, 02:00 by Bob Davis

Sep 23, 2022, 16:01 by Molly McGrath

Sep 20, 2022, 17:39 by Molly McGrath

Sep 20, 2022, 02:00 by Bob Davis

Sep 14, 2022, 14:17 by Molly McGrath

ASAM joined a coalition of public health, medical, and professional organizations in a letter to the Food and Drug Administration (FDA), supporting its intention to issue a proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels.